SCI

Analyst Note: Service Corporation International (SCI)

Date: 2026-06-20 Current Price: $72.62

1. Structural Readiness

• State: Context-Only (Forming Coil)
• Conservative Entry: Not yet actionable. A conservative entry requires a confirmed breakout above the resistance level defined by the coil's upper boundary.
• Aggressive/Pre-Breakout Entry: Not recommended for standard execution; the setup is currently in the "forming" phase.
• Breakout Level: Pending confirmation.
• Current Price: $72.62.
• Extension: Not applicable (price is within the consolidation range, not extended above the breakout).
• ATR Context: Current ATR is 2.9% (productive). This volatility is within the historical "sweet spot" (4–6% is ideal, but 2.9% indicates moderate, manageable volatility for a defensive operator). ATR at breakout is currently unmeasured as the breakout has not occurred.

2. Thesis Layer

• Thesis Classification: TACTICAL / Setup-Led.
• Macro Thesis: There is no named secular thesis attached to this specific setup at this date. While the company operates in a sector with long-term demographic tailwinds (Baby Boomer aging), the investment case here is strictly driven by the quality of the technical setup and the immediate fundamental strength recorded in the Q1 2026 earnings. We are judging this name on its setup quality and business fundamentals, not on a pre-defined macro narrative.

3. Business Overview

Service Corporation International (SCI) is the largest provider of deathcare products and services in North America. The company operates a network of funeral service locations and cemeteries, generating revenue through two primary channels:

• At-Need Sales: Services and merchandise sold at the time of death.
• Preneed Sales: Contracts sold in advance, funded via insurance or trust accounts, creating a massive deferred revenue backlog.

Key Fundamentals (as of Q1 2026):

• Scale: As of March 31, 2026, SCI operated 1,487 funeral service locations and 503 cemeteries across 44 states, eight Canadian provinces, D.C., and Puerto Rico. This represents a slight expansion from the 1,485 locations and 500 cemeteries reported at year-end 2025.
• Revenue Visibility: The company holds a $17.1 billion backlog of future revenue from trust and insurance-funded preneed sales as of March 31, 2026. This backlog grew from $17.0 billion at December 31, 2025, and $16.0 billion at December 31, 2024.
• Sales Growth: In the first quarter of 2026, comparable preneed cemetery sales production grew 10% ($32 million), driven by large sales ($20 million) and core sales ($12 million). Preneed funeral sales production increased 6% ($18 million).
• Financial Guidance: Management reaffirmed 2026 normalized EPS guidance of $4.05 to $4.35 and adjusted operating cash flow guidance of $1.0 billion to $1.06 billion.
• Cash Flow: Net cash provided by operating activities for the three months ended March 31, 2026, was $333.8 million, up from $311.1 million in the prior year quarter.
• Dividend: The quarterly dividend rate has grown steadily to $0.34 per share in 2026, up from $0.025 in 2005.

4. Archetype and Conviction

• Archetype: Defensive Operator.
• Fit: The business model is characterized by high visibility (backlog), consistent cash flow generation, and a defensive nature (demand for deathcare is inelastic). The company is not a cyclical recovery play or a high-growth tech leader; it is a mature operator leveraging scale and demographic inevitability.
• Valuation & Fundamentals:
• With a 2026 EPS guidance of $4.05–$4.35 and a current price of $72.62, the stock trades at a forward P/E of approximately 16.7x to 17.9x.
• The company targets a leverage ratio of 3.5x to 4.0x, which is consistent with its capital structure for a large-cap defensive operator.
• The "margin inflector" aspect is visible in the preneed sales growth; as the backlog converts to revenue, margins are supported by the pre-funded nature of the contracts.
• Conviction Stack:
• Thesis Strength: Moderate (Tactical, no macro thesis).
• Evidence Quality: High. Multiple data points confirm growth in preneed sales, strong cash flow, and stable guidance.
• Structural Quality: Positive. The backlog provides a "floor" for future revenue, and the company is actively acquiring (22 locations in 2025) to maintain market share (estimated 18%).
• Setup Readiness: Partial. The "Forming Coil" status indicates the market is digesting the recent earnings and guidance. The price is holding above support, but the breakout has not fired.
• Rerating Potential: Limited by the defensive nature of the sector, but supported by the consistent execution of the preneed strategy and the demographic tailwind (Baby Boomer aging) mentioned in management commentary.

5. Invalidations, Strengths, and Gaps

• What Would Strengthen: A confirmed breakout above the coil resistance level. Fundamentally, an acceleration in preneed sales growth or a successful integration of the new preferred insurance provider (agreed upon in July 2024) leading to margin expansion would strengthen the case.
• Gaps in Evidence:
• Breakout ATR: The ATR at the moment of breakout is unknown, which limits the ability to size the position based on volatility at the entry trigger.
• Sector Classification: The specific sector and industry labels are not provided in the evidence, though the business description clearly places it in the "Deathcare" or "Consumer Services" space.

PRIVATE ANALYST CALL

Judgment: Buy Confidence: medium Key evidence: $17.1 billion preneed backlog providing revenue visibility; Q1 2026 preneed cemetery sales up 10% and funeral sales up 6%; reaffirmed 2026 EPS guidance of $4.05-$4.35 with strong operating cash flow of $333.8 million. Key risks: Technical setup is "forming" and not yet a confirmed breakout; potential regulatory changes affecting preneed insurance/trust structures; demographic transition risks if Baby Boomer spending patterns shift. Sizing hint: Position size should reflect the "forming" status; smaller than a confirmed breakout trade, larger than a speculative long-only hold. Expected path: Management expects the year-over-year decline in volumes to moderate, leading to a 1-3% decline for the full year, while preneed sales continue to drive growth; the stock likely consolidates until a technical breakout confirms the fundamental strength. Expected horizon: 3 to 6 months for the technical setup to resolve into a confirmed breakout or invalidation.